{"entities":{"Q143755":{"pageid":145291,"ns":120,"title":"Item:Q143755","lastrevid":105361274,"modified":"2026-10-07T13:25:10Z","type":"item","id":"Q143755","labels":{"en":{"language":"en","value":"visit"}},"descriptions":{"en":{"language":"en","value":"Vaccine Phase I Design with Simultaneous Evaluation of Immunogenicity and Toxicity"}},"aliases":{},"claims":{"P132":[{"mainsnak":{"snaktype":"value","property":"P132","hash":"1c5be5aed0a570af0685fa77e251c15daf701b2c","datavalue":{"value":"2.1","type":"string"},"datatype":"string"},"type":"statement","qualifiers":{"P28":[{"snaktype":"value","property":"P28","hash":"5330ccce69685b24a519c48e9ea69d50ce476908","datavalue":{"value":{"time":"+2019-08-26T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"}]},"qualifiers-order":["P28"],"id":"Q143755$8E225FC9-1490-4952-B1AE-720E01256F3B","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P132","hash":"288deadfcc23b53f39b0a46cbcca3ebe74d73c37","datavalue":{"value":"2.2","type":"string"},"datatype":"string"},"type":"statement","qualifiers":{"P28":[{"snaktype":"value","property":"P28","hash":"9f4b69d9627ca0536bc3aceb4b7f5d82f38889e3","datavalue":{"value":{"time":"+2023-08-09T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"}]},"qualifiers-order":["P28"],"id":"Q143755$014D7951-CEBE-49B6-9066-77C02B0CE9A2","rank":"normal"}],"P229":[{"mainsnak":{"snaktype":"value","property":"P229","hash":"3305aedf4c62f003ba19e8ab4d512051c5217573","datavalue":{"value":"visit","type":"string"},"datatype":"external-id"},"type":"statement","qualifiers":{"P411":[{"snaktype":"value","property":"P411","hash":"fcf0eb7d1a1ce7dbd387921d06e155224ceb4762","datavalue":{"value":{"time":"+2025-06-12T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"}]},"qualifiers-order":["P411"],"id":"Q143755$176A9684-59C1-458B-A721-F1AF147F7EC1","rank":"normal"}],"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"438d0eef0223375d3a92def8ffc6a10a8bf1ca95","datavalue":{"value":{"entity-type":"item","numeric-id":57080,"id":"Q57080"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$EA990507-049E-4894-8997-577B46DE9BBF","rank":"normal"}],"P114":[{"mainsnak":{"snaktype":"value","property":"P114","hash":"251fd109c2cd8c1ee39b48cd109c9f4b1c9fcf5c","datavalue":{"value":{"entity-type":"item","numeric-id":13519,"id":"Q13519"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$EAB2A671-2A6B-4561-B189-8215D7D9661E","rank":"normal"}],"P19":[{"mainsnak":{"snaktype":"value","property":"P19","hash":"fb50964b729c869a3c602f82d7bcabb609f530eb","datavalue":{"value":{"entity-type":"item","numeric-id":113951,"id":"Q113951"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$D1405E32-AD25-44FC-9433-3346C336224F","rank":"normal"}],"P170":[{"mainsnak":{"snaktype":"value","property":"P170","hash":"adde9fa7b660455deb035dc59c88e644dd4f62c6","datavalue":{"value":{"time":"+2023-08-09T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q143755$ECAFA4B7-AC84-41CA-AC2B-E634447CE5F9","rank":"normal"}],"P1459":[{"mainsnak":{"snaktype":"value","property":"P1459","hash":"01f12b105e0d65bddf0e64803eeb2c5a4f071501","datavalue":{"value":"Phase I clinical trials are the first step in drug development to test    a new drug or drug combination on humans. Typical designs of Phase I     trials use toxicity as the primary endpoint and aim to find the maximum     tolerable dosage. However, these designs are poorly applicable for the     development of cancer therapeutic vaccines because the expected safety     concerns for these vaccines are not as much as cytotoxic agents. The     primary objectives of a cancer therapeutic vaccine phase I trial thus     often include determining whether the vaccine shows biologic activity     and the minimum dose necessary to achieve a full immune or even clinical     response. This package implements a Bayesian Phase I cancer vaccine    trial design that allows simultaneous evaluation of safety and    immunogenicity outcomes. See Wang et al. (2019) <doi:10.1002/sim.8021>    for further details.","type":"string"},"datatype":"string"},"type":"statement","id":"Q143755$EBE32841-0702-4A7E-AD4E-32CA2C1F0140","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"be3661e69334cac45045645521ca1e23c3191fe7","datavalue":{"value":{"entity-type":"item","numeric-id":113951,"id":"Q113951"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$77A44E45-EBC4-4261-9C85-2A9F78AF9F13","rank":"normal"}],"P163":[{"mainsnak":{"snaktype":"value","property":"P163","hash":"64cd73e553e7920a9cd11e3377fb75fd0effb226","datavalue":{"value":{"entity-type":"item","numeric-id":56634,"id":"Q56634"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P232":[{"snaktype":"value","property":"P232","hash":"08cd46e5d0670b30202d0ab659ba1ea1aef83363","datavalue":{"value":{"text":"\u2265 3","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"}]},"qualifiers-order":["P232"],"id":"Q143755$CF4637EC-1833-4FAE-AD01-D350FDDDEF34","rank":"normal"}],"P342":[{"mainsnak":{"snaktype":"value","property":"P342","hash":"6cbc80e2280919b8fb62581ce85d408be4c5aa56","datavalue":{"value":{"entity-type":"item","numeric-id":57177,"id":"Q57177"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$3CFA5E0B-0438-4A99-935A-5ABF341CFFE3","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P342","hash":"3af3346c5dd27e3d323c6b2b1e05c12991bf67e5","datavalue":{"value":{"entity-type":"item","numeric-id":27975,"id":"Q27975"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P132":[{"snaktype":"value","property":"P132","hash":"c163c28f28dfdbb81789b7988b9df33496db018e","datavalue":{"value":"\u2265 2.19.2","type":"string"},"datatype":"string"}]},"qualifiers-order":["P132"],"id":"Q143755$5BA86777-8FAF-4112-8903-3FBDF25C6B33","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P342","hash":"f04be079ac9f58f0680821f71264bc6283fc9503","datavalue":{"value":{"entity-type":"item","numeric-id":20394,"id":"Q20394"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P132":[{"snaktype":"value","property":"P132","hash":"518881395ac0727df2a51713289eb655767bdb82","datavalue":{"value":"\u2265 1.0.2","type":"string"},"datatype":"string"}]},"qualifiers-order":["P132"],"id":"Q143755$1565186E-E393-4E62-A095-291A2178BBB8","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P342","hash":"fe12f5e01d046912e5e7daea96ad81df7a13e944","datavalue":{"value":{"entity-type":"item","numeric-id":13519,"id":"Q13519"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P132":[{"snaktype":"value","property":"P132","hash":"d58e5b1027dfb6f2eb46f744a45ba1224fa0fc25","datavalue":{"value":"\u2265 3.5.0","type":"string"},"datatype":"string"}]},"qualifiers-order":["P132"],"id":"Q143755$F0A0C653-3B3F-4BF7-BA50-B4BBE5F343F9","rank":"normal"}],"P585":[{"mainsnak":{"snaktype":"value","property":"P585","hash":"ac7a4bb2f6411991d920a6a44acddbb1e59cddfc","datavalue":{"value":{"entity-type":"item","numeric-id":36621,"id":"Q36621"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P132":[{"snaktype":"value","property":"P132","hash":"0147c22d59f73f343377df4c66408834290acf6d","datavalue":{"value":"\u2265 0.4","type":"string"},"datatype":"string"}]},"qualifiers-order":["P132"],"id":"Q143755$60078B37-F0FE-4B7C-86F1-5BC5057C8B20","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P585","hash":"181574dfe61d92a30914c897a5022337ec55662b","datavalue":{"value":{"entity-type":"item","numeric-id":57412,"id":"Q57412"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P132":[{"snaktype":"value","property":"P132","hash":"7644f6e70449ba0f5d85ca2296d2aaa501d62740","datavalue":{"value":"\u2265 3.2","type":"string"},"datatype":"string"}]},"qualifiers-order":["P132"],"id":"Q143755$8E8049BF-C97D-484C-9F37-E555390E64BF","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P585","hash":"a6771e154926f64ee10bc450c397e577d6718026","datavalue":{"value":{"entity-type":"item","numeric-id":35540,"id":"Q35540"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","qualifiers":{"P132":[{"snaktype":"value","property":"P132","hash":"a89b157772ad8f7ff141a412bd8dca1536eb34f6","datavalue":{"value":"\u2265 5.0.2","type":"string"},"datatype":"string"}]},"qualifiers-order":["P132"],"id":"Q143755$D11D2A4B-00C1-4AF8-81A0-D8293FBE75D4","rank":"normal"}],"P223":[{"mainsnak":{"snaktype":"value","property":"P223","hash":"b65f06b20b1e718d889fae70b079c1c7bce2714c","datavalue":{"value":{"entity-type":"item","numeric-id":143754,"id":"Q143754"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$F27D2EE2-1FA2-4E78-B99D-30BB3EDFAD60","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"908c3454b3659c4b140ccce33c5aee31081edc8d","datavalue":{"value":{"entity-type":"item","numeric-id":5976450,"id":"Q5976450"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q143755$8ECAAC3A-B7EA-497C-BA7A-DF743DA0B263","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"414fad37d2f4475acb21c1762f71f7db85aba021","datavalue":{"value":"Zilu Wang","type":"string"},"datatype":"string"},"type":"statement","id":"Q143755$39CCB716-157A-4508-9255-BFB2A598D43D","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"f77cc6ef95c6f88ff93f617742bfe2c8017a11b5","datavalue":{"value":"Gary L Rosner","type":"string"},"datatype":"string"},"type":"statement","id":"Q143755$21FCCDCE-A5EC-427A-8E6B-A6CEC942C2F9","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"d36590cb8268eb5f8855f01d4635a5979f75806e","datavalue":{"value":"Richard B.s. Roden","type":"string"},"datatype":"string"},"type":"statement","id":"Q143755$98F41C3C-6419-468D-8B11-9DFF88887ECC","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Visit","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Visit"}}}}}